Variant position: 1661 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 1670 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human MFRKPIPSTVKAGELEKIIS RCQVCMKKRH
Mouse MFRKPIPSTVKAGDLEKIIS RCQVCMKKRH
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
29 – 1670 Collagen alpha-3(IV) chain
1426 – 1670 Tumstatin
1445 – 1669 Collagen IV NC1
1570 – 1665 Or C-1570 with C-1662
1604 – 1662 Or C-1604 with C-1665
1651 – 1651 S-Lysyl-methionine sulfilimine (Lys-Met) (interchain with M-1533)
1425 – 1670 Missing. In isoform 5.
1488 – 1670 GTLGSCLQRFTTMPFLFCNVNDVCNFASRNDYSYWLSTPALMPMNMAPITGRALEPYISRCTVCEGPAIAIAVHSQTTDIPPCPHGWISLWKGFSFIMFTSAGSEGTGQALASPGSCLEEFRASPFLECHGRGTCNYYSNSYSFWLASLNPERMFRKPIPSTVKAGELEKIISRCQVCMKKRH -> DALFVKVLRSP. In isoform 3.
1488 – 1670 GTLGSCLQRFTTMPFLFCNVNDVCNFASRNDYSYWLSTPALMPMNMAPITGRALEPYISRCTVCEGPAIAIAVHSQTTDIPPCPHGWISLWKGFSFIMFTSAGSEGTGQALASPGSCLEEFRASPFLECHGRGTCNYYSNSYSFWLASLNPERMFRKPIPSTVKAGELEKIISRCQVCMKKRH -> ESLFHQL. In isoform 4.
1586 – 1670 FTSAGSEGTGQALASPGSCLEEFRASPFLECHGRGTCNYYSNSYSFWLASLNPERMFRKPIPSTVKAGELEKIISRCQVCMKKRH -> KAYSINCESWGIRKNNKSLSGVHEEKTLKLKKTAELVFFILKNKVMTEHAVI. In isoform 2.
Structure of the human type IV collagen gene COL4A3 and mutations in autosomal Alport syndrome.
Heidet L.; Arrondel C.; Forestier L.; Cohen-Solal L.; Mollet G.; Gutierrez B.; Stavrou C.; Gubler M.-C.; Antignac C.;
J. Am. Soc. Nephrol. 12:97-106(2001)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1); VARIANTS APSAR GLU-297; ARG-407; ARG-640; GLU-1207; GLN-1215; SER-1277; THR-1330; GLU-1334; GLU-1347 AND CYS-1661; VARIANT APSAD ARG-1167; VARIANTS ARG-43; PRO-141; TYR-326; HIS-408; ARG-451; GLU-1269 AND PRO-1474;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.